Carrier screening is used to identify individuals or couples that are at risk of passing on a genetic condition to their child. Once
identified, carriers of these disorders can be educated about their risks and have the opportunity to make alternative reproductive
options. By carrier screening, carriers could be more prepared for a baby who may be affected by a genetic condition mentally and
financially.

 
BGI VISTA™ Carrier Screening can be your priority selection whether you are wanting to have a baby or already pregnant.
VISTA™ Carrier Screening offers you multiple panel options (Mini, Targeted, & 1200+) to fit with your own condition. The latest
released 1200+ panel product can detect over 1,200 genes, more than 1200 genetic disorders are covered, providing carriers with
educational summarized information.

BGI VISTA™ Carrier Screening covers most common disease such as:

• Duchenne Muscular Dystrophy – the most common form of muscular dystrophy affecting children.

• Wilson disease – Worldwide 1 in 30,000 people have Wilson disease.

• Cystic fibrosis – one of the most common deadly inherited disorder among Caucasians.

• Spinal Muscular Atrophy – 1 in 50 people found to be a carrier of this disease.

• Glycogen Storage Disease – The most comprehensive coverage for all types of pomp disease in the market.

• Safe – test from just peripheral blood or saliva

• Cost effective – screen for multiple disease with high accuracy

• Flexible – comprehensive or targeted panel options available



Note: this test is considered a screening test, not a diagnostic test. Before making any treatment decisions, all patients should discuss their results with their healthcare provider, who can recommend confirmatory, diagnostic testing where appropriate. This testing service has not been cleared or approved by the US FDA and is not available in the USA.